Surgical Strategies in Ovarian Cancer

This chapter explores the distinct treatment approaches for early and late-stage ovarian cancer, emphasizing the critical role of surgical intervention. It discusses the significance of surgical candidates and upfront surgery to optimize outcomes, while also addressing the challenges of effective screening. Additionally, advancements in therapy, such as PARP inhibitors and antibody drug conjugates, are highlighted for their beneficial impact on survival rates.